[1]
|
中国心血管健康与疾病报告编写组. 中国心血管健康与疾病报告2021概要[J]. 中国循环杂志, 2022, 37(6): 553-578.
|
[2]
|
Reamy, B.V., Williams, P.M. and Kuckel, D.P. (2018) Prevention of Cardiovascular Disease. Primary Care, 45, 25-44.
https://doi.org/10.1016/j.pop.2017.11.003
|
[3]
|
Watanabe, T., Watanabe-Kominato, K., Takahashi, Y., Kojima, M. and Watanabe, R. (2017) Adipose Tissue-Derived Omentin-1 Function and Regulation. Comprehensive Physiology, 7, 765-781. https://doi.org/10.1002/cphy.c160043
|
[4]
|
Van de Voorde, J., Pauwels, B., Boydens, C. and Decaluwe, K. (2013) Adipocytokines in Relation to Cardiovascular Disease. Metabolism, 62, 1513-1521. https://doi.org/10.1016/j.metabol.2013.06.004
|
[5]
|
Kern, P.A., Lu, T., Rassouli, N. and Ranganathan, G. (2003) Adiponectin Expression from Human Adipose Tissue: Relation to Obesity, Insulin Resistance, and Tumor Necrosis Fac-tor-Alpha Expression. Diabetes, 52, 1779-1785.
https://doi.org/10.2337/diabetes.52.7.1779
|
[6]
|
Lee, B. and Shao, J. (2014) Adiponectin and Energy Homeostasis. Reviews in Endocrine and Metabolic Disorders, 15, 149-156. https://doi.org/10.1007/s11154-013-9283-3
|
[7]
|
Ohashi, K., Ouchi, N. and Matsuzawa, Y. (2012) An-ti-Inflammatory and Anti-Atherogenic Properties of Adiponectin. Biochimie, 94, 2137-2142. https://doi.org/10.1016/j.biochi.2012.06.008
|
[8]
|
Inoue, T., Kotooka, N., Morooka, T., Komoda, H., Uchida, T., Aso, Y., et al. (2007) High Molecular Weight Adiponectin as a Predictor of Long-Term Clinical Outcome in Patients with Coronary Artery Disease. American Journal of Cardiology, 100, 569-574. https://doi.org/10.1016/j.amjcard.2007.03.062
|
[9]
|
Zhang, M., Chen, X., Zhu, Y., Yin, L., Quan, Z., Ou, Y., et al. (2022) Causal Associations of Circulating Adiponectin with Cardiometabolic Diseases and Osteoporotic Fracture. Scien-tific Reports, 12, Article No. 6689.
https://doi.org/10.1038/s41598-022-10586-1
|
[10]
|
Di Chiara, T., Licata, A., Argano, C., Duro, G., Corrao, S. and Scaglione, R. (2014) Plasma Adiponectin: A Contributing Factor for Cardiac Changes in Visceral Obesity-Associated Hypertension. Blood Pressure, 23, 147-153.
https://doi.org/10.3109/08037051.2013.823767
|
[11]
|
Chen, Z., Peng, I.C., Sun, W., Su, M.I., Hsu, P.H., Fu, Y., et al. (2009) AMP-Activated Protein Kinase Functionally Phosphorylates Endothelial Nitric Oxide Synthase Ser633. Cir-culation Research, 104, 496-505.
https://doi.org/10.1161/CIRCRESAHA.108.187567
|
[12]
|
Kim, Y., Lim, J.H., Kim, E.N., Hong, Y.A., Park, H.J., Chung, S., et al. (2022) Adiponectin Receptor agonist Ameliorates Cardiac Lipotoxicity via Enhancing Ceramide Metab-olism in Type 2 Diabetic Mice. Cell Death & Disease, 13, Article No. 282. https://doi.org/10.1038/s41419-022-04726-8
|
[13]
|
Ouchi N KS, Arita, Y., Nishida, M., Matsuyama, A., Okamoto, Y., Ishigami, M., Kuriyama, H., et al. (2001) Adipocyte-Derived Plasma Protein, Adiponectin, Suppresses Lipid Accu-mulation and Class A Scavenger Receptor Expression in Human Monocyte-Derived Macrophages. Circulation, 103, 1057-1063.
https://doi.org/10.1161/01.CIR.103.8.1057
|
[14]
|
Naryzhnaya, N.V., Koshelskaya, O.A., Kologrivova, I.V., Suslova, T.E., Kharitonova, O.A., Andreev, S.L., et al. (2022) Production of Reactive Oxygen Species by Epicardial Adipocytes Is Associated with an Increase in Postprandial Glycemia, Postprandial Insulin, and a Decrease in Serum Adiponectin in Patients with Severe Coronary Atherosclerosis. Biomedicines, 10, Article No. 2054. https://doi.org/10.3390/biomedicines10082054
|
[15]
|
George, J., Patal, S., Wexler, D., Sharabi, Y., Peleg, E., Kamari, Y., et al. (2006) Circulating Adiponectin Concentrations in Patients with Congestive Heart Failure. Heart, 92, 1420-1424. https://doi.org/10.1136/hrt.2005.083345
|
[16]
|
Kojima, S., Funahashi, T., Otsuka, F., Maruyoshi, H., Yamashita, T., Kajiwara, I., et al. (2007) Future Adverse Cardiac Events Can Be Predicted by Persistently Low Plasma Adiponectin Concentrations in Men and Marked Reductions of Adiponectin in Women after Acute Myocardial Infarction. Athero-sclerosis, 194, 204-213.
https://doi.org/10.1016/j.atherosclerosis.2006.07.028
|
[17]
|
Zhang Y PR, Maffei, M., Barone, M., Leopold, L. and Friedman, J.M. (1994) Positional Cloning of the Mouse Obese Gene and Its Human Homologue. Nature, 372, 425-32. https://doi.org/10.1038/372425a0
|
[18]
|
Friedman, J.M. (1998) Leptin, Leptin Receptors, and the Control of Body Weight. Nutrition Reviews, 56, S38-S46.
https://doi.org/10.1111/j.1753-4887.1998.tb01685.x
|
[19]
|
Liberale, L., Bonaventura, A., Vecchie, A., Casula, M., Dallegri, F., Montecucco, F., et al. (2017) The Role of Adipocytokines in Coronary Atherosclerosis. Current Athero-sclerosis Reports, 19, Article No. 21.
https://doi.org/10.1007/s11883-017-0657-y
|
[20]
|
Vasamsetti, S.B., Natarajan, N., Sadaf, S., Florentin, J. and Dutta, P. (2022) Regulation of Cardiovascular Health and Disease by Visceral Adipose Tissue-Derived Metabolic Hormones. The Journal of Physiology.
https://doi.org/10.1113/JP282728
|
[21]
|
Huang, F., Xiong, X., Wang, H., You, S. and Zeng, H. (2010) Lep-tin-Induced Vascular Smooth Muscle Cell Proliferation via Regulating Cell Cycle, Activating ERK1/2 and NF-κB. Acta Biochim Biophys Sin (Shanghai), 42, 325-331.
https://doi.org/10.1093/abbs/gmq025
|
[22]
|
Cirillo, P., Angri, V., De Rosa, S., Cali, G., Petrillo, G., Maresca, F., et al. (2010) Pro-Atherothrombotic Effects of Leptin in Human Coronary Endothelial Cells. Thrombosis and Haemostasis, 103, 1065-1075.
https://doi.org/10.1160/TH09-06-0392
|
[23]
|
Puurunen, V.P., Kiviniemi, A., Lepojarvi, S., Piira, O.P., Hedberg, P., Junttila, J., et al. (2017) Leptin Predicts Short- Term Major Adverse Cardiac Events in Patients with Coronary Artery Disease. Annals of Medicine, 49, 448-454.
https://doi.org/10.1080/07853890.2017.1301678
|
[24]
|
Hasan-Ali, H., Abd El-Mottaleb, N.A., Hamed, H.B. and Abd-Elsayed, A. (2011) Serum Adiponectin and Leptin as Predictors of the Presence and Degree of Coronary Athero-sclerosis. Coronary Artery Disease, 22, 264-269.
https://doi.org/10.1097/MCA.0b013e3283452431
|
[25]
|
Faxen, U.L., Hage, C., Andreasson, A., Donal, E., Daubert, J.C., Linde, C., et al. (2017) HFpEF and HFrEF Exhibit Different Phenotypes as Assessed by Leptin and Adiponectin. International Journal of Cardiology, 228, 709-716.
https://doi.org/10.1016/j.ijcard.2016.11.194
|
[26]
|
Bidulescu, A., Liu, J., Chen, Z., Hickson, D.A., Musani, S.K., Samdarshi, T.E., et al. (2013) Associations of Adiponectin and Leptin with Incident Coronary Heart Disease and Is-chemic Stroke in African Americans: The Jackson Heart Study. Frontiers in Public Health, 1, Article No. 16. https://doi.org/10.3389/fpubh.2013.00016
|
[27]
|
Yang, H., Guo, W., Li, J., Cao, S., Zhang, J., Pan, J., et al. (2017) Leptin Concentration and Risk of Coronary Heart Disease and Stroke: A Systematic Review and Meta-Analysis. PLOS ONE, 12, e0166360.
https://doi.org/10.1371/journal.pone.0166360
|
[28]
|
Seven, E., Husemoen, L.L., Sehested, T.S., Ibsen, H., Wachtell, K., Linneberg, A., et al. (2015) Adipocytokines, C-Reactive Protein, and Cardiovascular Disease: A Population-Based Prospective Study. PLOS ONE, 10, Article ID: e0128987. https://doi.org/10.1371/journal.pone.0128987
|
[29]
|
Romere, C., Duerrschmid, C., Bournat, J., Constable, P., Jain, M., Xia, F., et al. (2016) Asprosin, a Fasting-Induced Glucogenic Protein Hormone. Cell, 165, 566-579. https://doi.org/10.1016/j.cell.2016.02.063
|
[30]
|
Duerrschmid, C., He, Y., Wang, C., Li, C., Bournat, J.C., Romere, C., et al. (2017) Asprosin Is a Centrally Acting Orexigenic Hormone. Nature Medicine, 23, 1444-1453. https://doi.org/10.1038/nm.4432
|
[31]
|
Moradi, N., Fouani, F.Z., Vatannejad, A., Bakhti Arani, A., Shahrzad, S. and Fadaei, R. (2021) Serum Levels of Asprosin in Patients Diagnosed with Coronary Artery Disease (CAD): A Case-Control Study. Lipids in Health and Disease, 20, Article No. 88. https://doi.org/10.1186/s12944-021-01514-9
|
[32]
|
Ovali, M.A. and Bozgeyik, I. (2022) Asprosin, a C-Terminal Cleavage Product of Fibrillin 1 Encoded by the FBN1 Gene, in Health and Disease. Molecular Syndromology, 13, 175-183. https://doi.org/10.1159/000520333
|
[33]
|
Zhu, Q., Ni, X.Q., Lu, W.W., Zhang, J.S., Ren, J.L., Wu, D., et al. (2017) Intermedin Reduces Neointima Formation by Regulating Vascular Smooth Muscle Cell Phenotype via cAMP/PKA Pathway. Atherosclerosis, 266, 212-222.
https://doi.org/10.1016/j.atherosclerosis.2017.10.011
|
[34]
|
Wang, R. and Hu, W. (2021) Asprosin Promotes Be-ta-Cell Apoptosis by Inhibiting the Autophagy of Beta-Cell via AMPK-mTOR Pathway. Journal of Cellular Physiology, 236, 215-221. https://doi.org/10.1002/jcp.29835
|
[35]
|
Lee, T., Yun, S., Jeong, J.H. and Jung, T.W. (2019) Aspros-in Impairs Insulin Secretion in Response to Glucose and viability through TLR4/JNK-mediated inflammation. Molecular and Cellular Endocrinology, 486, 96-104.
https://doi.org/10.1016/j.mce.2019.03.001
|
[36]
|
Zou, J., Xu, C., Zhao, Z.W., Yin, S.H. and Wang, G. (2022) Asprosin Inhibits Macrophage Lipid Accumulation and Reduces Atherosclerotic Burden by Up-Regulating ABCA1 and ABCG1 Expression via the p38/Elk-1 Pathway. Journal of Translational Medicine 20, Article No. 337. https://doi.org/10.1186/s12967-022-03542-0
|
[37]
|
Guven, C. and Kafadar, H. (2022) Evaluation of Plasma Asprosin Concentration in Patients with Coronary Artery Disease. Brazilian Journal of Cardiovascular Surgery, 37, 493-500. https://doi.org/10.21470/1678-9741-2021-0003
|
[38]
|
徐佰达, 叶挺, 王倩, 马涛, 刘洁, 宗刚军. 血浆白脂素水平与冠心病的关系[J]. 心脏杂志, 2019, 31(4): 428-431.
|
[39]
|
Wang, H.H., Luo, W.Y., Lin, M., Li, X.J., Xiang, G.D. and Triganti, D.T. (2021) Plasma Asprosin, CCDC80 and ANGPTL4 Levels Are Associated with Meta-bolic and Cardiovascular Risk in Patients with Inflammatory Bowel Disease. Physiological Research, 70, 203-211. https://doi.org/10.33549/physiolres.934547
|
[40]
|
Zhang, Z., Tan, Y., Zhu, L., Zhang, B., Feng, P., Gao, E., et al. (2019) Asprosin Improves the Survival of Mesenchymal Stromal Cells in Myocardial Infarction by Inhibiting Apoptosis via the Activated ERK1/2-SOD2 Pathway. Life Sciences, 231, Article ID: 116554. https://doi.org/10.1016/j.lfs.2019.116554
|
[41]
|
Deng, X., Zhao, Z., Zhao, L., Wang, C., Li, Y., Cai, Z., et al. (2022) Association between Circulating Asprosin Levels and Carotid Atherosclerotic Plaque in Patients with Type 2 Diabetes. Clinical Biochemistry.
https://doi.org/10.1016/j.clinbiochem.2022.04.018
|